TTR and axial length measurement: In the contemporary cohort, ATTR-CA was associated with more favorable global and cardiovascular outcomes compared to AL-CA, reflecting the major advances in earlier diagnosis and treatment, especially for ATTR amyloidosis (Figure 4).